For citations:
Dolgasheva D.S., Pevzner A.M., Ibragimova M.K., Litvyakov N.V., Tsyganov M.M. PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use. Tumors of female reproductive system. 2020;16(1):55-64. (In Russ.) https://doi.org/10.17650/1994-4098-2020-16-1-55-64
Email this article 